Hosted on MSN1mon
Saluda Medical secures $100m for Evoke System commercialisation
Saluda Medical has completed a $100m financing ... The platform claims to operate by delivering spinal cord stimulation (SCS) therapy that senses and measures neural activation, with an aim ...
GEN9d
Spinal Cord Stimulation Improves Leg Strength and Walking in Adults with SMA
In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.
The Victoria Advocate10d
Saluda Medical Announces Presentation of New Clinical Data at the 2025 NANS Annual Meeting
MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Saluda Medical ... of objective neurophysiological measurements in spinal cord stimulation (SCS) with evoked compound action potential (ECAP) dose ...